PFE - Pfizer Stock Nears Golden Cross Signals Potential Upside With Strong Oncology Portfolio | Benzinga
Pfizer Inc (NYSE:PFE), one of the world’s largest pharmaceutical firms, is on the verge of a bullish Golden Cross, a significant technical indicator suggesting potential upward momentum for the stock.
Currently, PFE stock is trading at around $30, showing a year-to-date gain of 2.6%, despite being down 16% over the past year.
Chart created using Benzinga Pro
The golden cross, where the short-term moving average crosses above the long-term moving average, is viewed by traders as a bullish signal.
Chart created using Benzinga Pro
Pfizer’s share price is above its 5, 20, and 50-day exponential moving averages, indicating a strong bullish trend. Specifically, PFE stock is trading above ...